Concepedia

C. Aghajanian

CA

Statistics

Publications

2

Citations

48

H-Index

2

Active since

2006

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

C. Aghajanian is an author at Memorial Sloan Kettering Cancer Center specializing in chemotherapy, oncology pharmacotherapy, and medicine.

Publications per year

2006–2011

2

Publications

2

OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC).

C. Aghajanian, N. Finkler, T. Rutherford et al. · Journal of Clinical Oncology · 2011 · 35 citations

, , +14

Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer

Fernando Cotait Maluf, Aliza Leiser, C. Aghajanian et al. · International Journal of Gynecological Cancer · 2006 · 13 citations

, , +17

1–2 of 2